Press release
May 13, 2026
Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering with Existing Holders and a Single Institutional Investor
Lantern Pharma Inc. (LTRN)
We couldn't retrieve the full text for this release. Read it on the company's site.